2 results match your criteria: "Campus University Clinic Brandenburg[Affiliation]"
Acta Physiol (Oxf)
February 2022
Brandenburg Medical School Theodor Fontane (MHB), Deutsche Angiologie Zentrum Brandenburg-Berlin (DAZB), Department for Angiology, Center for Internal Medicine I, Campus University Clinic Brandenburg, Brandenburg an der Havel, Germany.
Vasa
November 2021
Department for Angiology, Center for Internal Medicine I, Brandenburg Medical School Theodor Fontane, Campus University Clinic Brandenburg, Deutsches Angiologie Zentrum Brandenburg-Berlin (DAZB), Brandenburg an der Havel, Germany.
Angiotensin-converting-enzyme inhibitors (ACEI) and angiotensin II receptor blockers (ARB) are widely used as a first-line therapy for the treatment of cardiovascular disease. Here, ACEI modulate the bradykinin receptor (BDKRB1 and BDKRB2) system and NO-dependent endothelial function, thus determining cardiovascular health and regenerative arteriogenesis. The current study aims at evaluating nitric oxide-dependent endothelial function, and gene expression of bradykinin receptors in peripheral blood mononuclear cells (PBMC) from patients with ACEI or ARB treatment.
View Article and Find Full Text PDF